Developing a COVID-19 Mortality Prediction (CoMPred) Indicator for ICU Diabetic Patients Treated with Tocilizumab in Saudi Arabia: A Proof-of-Concept Study
Biomedicines This article aims to present a novel and objective laboratory-based indicator to predict mortality among COVID-19 patients and finds that diabetic status can differentiate between severe and non-severe cases of COVID-19 but cannot predict mortality. Journal Article
Read More